{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T15:41:46Z","timestamp":1784734906213,"version":"3.55.0"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T00:00:00Z","timestamp":1759449600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006595","name":"Executive Unit for Financing Higher Education Research Development and Innovation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006730","name":"Ministry of Education and Research, Romania","doi-asserted-by":"publisher","award":["PN-III-P1-1.1-PD-2019-0468"],"award-info":[{"award-number":["PN-III-P1-1.1-PD-2019-0468"]}],"id":[{"id":"10.13039\/501100006730","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.bcp.2025.117386","type":"journal-article","created":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T06:26:13Z","timestamp":1759472773000},"page":"117386","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"P3","title":["Curcumin reverses irinotecan-acquired resistance in DLD1 colorectal cancer cells: Insights from whole transcriptomic data"],"prefix":"10.1016","volume":"242","author":[{"given":"Laura","family":"Gavrilas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oana","family":"Sava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loredana","family":"Balacescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Miron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doina","family":"Miere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ovidiu","family":"Balacescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Cruceriu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.bcp.2025.117386_b0005","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"issue":"3","key":"10.1016\/j.bcp.2025.117386_b0010","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1200\/JCO.22.01690","article-title":"Treatment of metastatic colorectal cancer: ASCO Guideline","volume":"41","author":"Morris","year":"2023","journal-title":"JCO"},{"issue":"4","key":"10.1016\/j.bcp.2025.117386_b0015","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.tips.2023.01.003","article-title":"Metastatic colorectal cancer: mechanisms and emerging therapeutics","volume":"44","author":"Shin","year":"2023","journal-title":"Trends Pharmacol. Sci."},{"issue":"1","key":"10.1016\/j.bcp.2025.117386_b0020","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1177\/1758834015614530","article-title":"Pharmacologic resistance in colorectal cancer: a review","volume":"8","author":"Hammond","year":"2016","journal-title":"Therapeut. Adv. Med. Oncol."},{"issue":"3","key":"10.1016\/j.bcp.2025.117386_b0025","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1055\/s-0036-1584292","article-title":"The multidisciplinary management of colorectal cancer: present and future paradigms","volume":"29","author":"Sievers","year":"2016","journal-title":"Clin. Colon Rectal Surg."},{"issue":"9","key":"10.1016\/j.bcp.2025.117386_b0030","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.3390\/biomedicines9091086","article-title":"The role of curcumin in cancer treatment","volume":"9","author":"Zoi","year":"2021","journal-title":"Biomedicines"},{"issue":"6","key":"10.1016\/j.bcp.2025.117386_b0035","doi-asserted-by":"crossref","first-page":"3717","DOI":"10.1039\/C9FO01014A","article-title":"Pro-apoptotic genes as new targets for single and combinatorial treatments with resveratrol and curcumin in colorectal cancer","volume":"10","author":"Gavrilas","year":"2019","journal-title":"Food Funct."},{"key":"10.1016\/j.bcp.2025.117386_b0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2021.153547","article-title":"Low curcumin concentration enhances the anticancer effect of 5-fluorouracil against colorectal cancer","volume":"85","author":"Zheng","year":"2021","journal-title":"Phytomedicine"},{"key":"10.1016\/j.bcp.2025.117386_b0045","doi-asserted-by":"crossref","unstructured":"Guo L da, Shen Y qing, Zhao X han, et al. Curcumin combined with oxaliplatin effectively suppress colorectal carcinoma in vivo through inducing apoptosis. Phytother Res. 2015;29(3):357-365. doi:10.1002\/ptr.5257.","DOI":"10.1002\/ptr.5257"},{"issue":"25","key":"10.1016\/j.bcp.2025.117386_b0050","doi-asserted-by":"crossref","first-page":"40264","DOI":"10.18632\/oncotarget.16828","article-title":"Curcumin enhances the effects of irinotecan on colorectal cancer cells through the generation of reactive oxygen species and activation of the endoplasmic reticulum stress pathway","volume":"8","author":"Huang","year":"2017","journal-title":"Oncotarget"},{"issue":"3","key":"10.1016\/j.bcp.2025.117386_b0055","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1093\/carcin\/bgv006","article-title":"Curcumin mediates chemosensitization to 5-fluorouracil through miRNA-induced suppression of epithelial-to-mesenchymal transition in chemoresistant colorectal cancer","volume":"36","author":"Toden","year":"2015","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.bcp.2025.117386_b0060","article-title":"Curcumin mediates oxaliplatin-acquired resistance reversion in colorectal cancer cell lines through modulation of CXC-Chemokine\/NF-\u03baB signalling pathway","volume":"6(1):24675","author":"Ruiz de Porras","year":"2016","journal-title":"Sci. Rep."},{"issue":"7","key":"10.1016\/j.bcp.2025.117386_b0065","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1093\/jn\/nxz029","article-title":"Curcumin combined with FOLFOX chemotherapy is safe and tolerable in patients with metastatic colorectal cancer in a randomized phase iia trial","volume":"149","author":"Howells","year":"2019","journal-title":"J. Nutr."},{"issue":"1","key":"10.1016\/j.bcp.2025.117386_b0070","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1186\/s12885-020-07256-8","article-title":"Clinical effects of curcumin in enhancing cancer therapy: a systematic review","volume":"20","author":"Mansouri","year":"2020","journal-title":"BMC Cancer"},{"issue":"5","key":"10.1016\/j.bcp.2025.117386_b0075","first-page":"2729","article-title":"RNA-seq reveals determinants for irinotecan sensitivity\/resistance in colorectal cancer cell lines","volume":"7","author":"Li","year":"2014","journal-title":"Int. J. Clin. Exp. Pathol."},{"issue":"4","key":"10.1016\/j.bcp.2025.117386_b0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3892\/ol.2022.13226","article-title":"PI3K\/Akt\/YAP signaling promotes migration and invasion of DLD\u20111 colorectal cancer cells","volume":"23","author":"Takeda","year":"2022","journal-title":"Oncol. Lett."},{"issue":"4","key":"10.1016\/j.bcp.2025.117386_b0085","doi-asserted-by":"crossref","first-page":"245","DOI":"10.2165\/00003088-199733040-00001","article-title":"Clinical pharmacokinetics of irinotecan","volume":"33","author":"Chabot","year":"1997","journal-title":"Clin. Pharmacokinet."},{"issue":"2","key":"10.1016\/j.bcp.2025.117386_b0090","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1158\/0008-5472.CAN-09-1947","article-title":"Drug combination studies and their synergy quantification using the Chou-Talalay method","volume":"70","author":"Chou","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.bcp.2025.117386_b0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2019.104398","article-title":"Irinotecan: 25 years of cancer treatment","volume":"148","author":"Bailly","year":"2019","journal-title":"Pharmacol. Res."},{"issue":"8\u20139","key":"10.1016\/j.bcp.2025.117386_b0100","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1039\/b908595e","article-title":"Spontaneous migration of cancer cells under conditions of mechanical confinement","volume":"1","author":"Irimia","year":"2009","journal-title":"Integr Biol (camb)."},{"issue":"7","key":"10.1016\/j.bcp.2025.117386_b0105","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1093\/nar\/gkv007","article-title":"limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res."},{"issue":"4","key":"10.1016\/j.bcp.2025.117386_b0110","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.bcp.2025.117386_b0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.adcanc.2024.100114","article-title":"Multi drug resistance in Colorectal Cancer- approaches to overcome, advancements and future success","volume":"10","author":"Ashique","year":"2024","journal-title":"Adv. Cancer Biol-Metastasis."},{"issue":"8","key":"10.1016\/j.bcp.2025.117386_b0120","first-page":"2182","article-title":"Clinical pharmacokinetics and metabolism of irinotecan (CPT-11)","volume":"7","author":"Mathijssen","year":"2001","journal-title":"Clin. Cancer Res."},{"issue":"8","key":"10.1016\/j.bcp.2025.117386_b0125","first-page":"2605","article-title":"Human carboxylesterase 2 is commonly expressed in tumor tissue and is correlated with activation of irinotecan","volume":"8","author":"Xu","year":"2002","journal-title":"Clin. Cancer Res."},{"issue":"13","key":"10.1016\/j.bcp.2025.117386_b0130","first-page":"4983","article-title":"Carboxylesterases expressed in human colon tumor tissue and their role in CPT-11 hydrolysis","volume":"9","author":"Sanghani","year":"2003","journal-title":"Clin. Cancer Res."},{"issue":"10","key":"10.1016\/j.bcp.2025.117386_b0140","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1007\/s40262-018-0644-7","article-title":"Individualization of irinotecan treatment: a review of pharmacokinetics, pharmacodynamics, and pharmacogenetics","volume":"57","author":"de Man","year":"2018","journal-title":"Clin. Pharmacokinet."},{"issue":"3","key":"10.1016\/j.bcp.2025.117386_b0145","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1080\/15376516.2022.2109229","article-title":"Effects of common genetic variants of human uridine diphosphate glucuronosyltransferase subfamilies on irinotecan glucuronidation","volume":"33","author":"Tagawa","year":"2023","journal-title":"Toxicol. Mech. Methods"},{"issue":"9","key":"10.1016\/j.bcp.2025.117386_b0150","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1038\/s41416-019-0722-0","article-title":"Emerging roles for UDP-glucuronosyltransferases in drug resistance and cancer progression","volume":"122","author":"Allain","year":"2020","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bcp.2025.117386_b0155","doi-asserted-by":"crossref","unstructured":"Fujita K ichi, Kubota Y, Ishida H, Sasaki Y. Irinotecan, a key chemotherapeutic drug for metastatic colorectal cancer. World J Gastroenterol. 2015;21(43):12234-12248. doi:10.3748\/wjg.v21.i43.12234.","DOI":"10.3748\/wjg.v21.i43.12234"},{"issue":"2","key":"10.1016\/j.bcp.2025.117386_b0160","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.pharmthera.2009.05.011","article-title":"Cooperative properties of cytochromes P450","volume":"124","author":"Denisov","year":"2009","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.bcp.2025.117386_b0165","doi-asserted-by":"crossref","unstructured":"Singh RD, Avadhesh A, Sharma G, et al. Potential of Cytochrome P450, a Family of Xenobiotic Metabolizing Enzymes, in Cancer Therapy. Antioxidants & Redox Signaling. 2023;38(10-12):853-876. doi:10.1089\/ars.2022.0116.","DOI":"10.1089\/ars.2022.0116"},{"issue":"3","key":"10.1016\/j.bcp.2025.117386_b0170","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1124\/pharmrev.120.000122","article-title":"Aldo-Keto reductases and cancer drug resistance","volume":"73","author":"Penning","year":"2021","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.bcp.2025.117386_b0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2020.109295","article-title":"Significance of aldo-keto reductase 1C3 and ATP-binding cassette transporter B1 in gain of irinotecan resistance in colon cancer cells","volume":"332","author":"Matsunaga","year":"2020","journal-title":"Chem. Biol. Interact."},{"issue":"4","key":"10.1016\/j.bcp.2025.117386_b0180","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/s12038-010-0064-9","article-title":"Proteomic analysis of cell lines to identify the irinotecan resistance proteins","volume":"35","author":"Peng","year":"2010","journal-title":"J. Biosci."},{"issue":"4","key":"10.1016\/j.bcp.2025.117386_b0185","first-page":"946","article-title":"Cellular irinotecan resistance in colorectal cancer and overcoming irinotecan refractoriness through various combination trials including DNA methyltransferase inhibitors: a review","volume":"4","author":"Ozawa","year":"2021","journal-title":"Cancer Drug Resist."},{"issue":"1","key":"10.1016\/j.bcp.2025.117386_b0190","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/tpj.2016.75","article-title":"ABC transporter polymorphisms are associated with irinotecan pharmacokinetics and neutropenia","volume":"18","author":"Li","year":"2018","journal-title":"Pharmacogenomics J"},{"issue":"12","key":"10.1016\/j.bcp.2025.117386_b0195","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1097\/FPC.0000000000000168","article-title":"ABCC5 and ABCG1 polymorphisms predict irinotecan-induced severe toxicity in metastatic colorectal cancer patients","volume":"25","author":"Chen","year":"2015","journal-title":"Pharmacogenet. Genomics"},{"issue":"1","key":"10.1016\/j.bcp.2025.117386_b0200","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.canlet.2008.12.033","article-title":"Molecular changes to HeLa cells on continuous exposure to SN-38, an active metabolite of irinotecan hydrochloride","volume":"278","author":"Takara","year":"2009","journal-title":"Cancer Lett."},{"issue":"5","key":"10.1016\/j.bcp.2025.117386_b0205","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.3892\/ijo.2013.1868","article-title":"Acquired irinotecan resistance is accompanied by stable modifications of cell cycle dynamics independent of MSI status","volume":"42","author":"Petitprez","year":"2013","journal-title":"Int. J. Oncol."},{"issue":"1","key":"10.1016\/j.bcp.2025.117386_b0210","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s12964-023-01302-1","article-title":"Unveiling the mechanisms and challenges of cancer drug resistance","volume":"22","author":"Khan","year":"2024","journal-title":"Cell Commun. Signaling"},{"issue":"3","key":"10.1016\/j.bcp.2025.117386_b0215","doi-asserted-by":"crossref","first-page":"338","DOI":"10.3390\/cancers11030338","article-title":"Chemotherapy resistance explained through endoplasmic reticulum stress-dependent signaling","volume":"11","author":"Bahar","year":"2019","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.bcp.2025.117386_b0220","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s12943-017-0657-0","article-title":"PERK induces resistance to cell death elicited by endoplasmic reticulum stress and chemotherapy","volume":"16","author":"Salaroglio","year":"2017","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bcp.2025.117386_b0225","doi-asserted-by":"crossref","first-page":"3210","DOI":"10.1038\/s41598-019-39547-x","article-title":"Activation of the PERK-ATF4 pathway promotes chemo-resistance in colon cancer cells","volume":"9","author":"Shi","year":"2019","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.bcp.2025.117386_b0230","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.bbrc.2012.11.105","article-title":"Dimerization of pro-oncogenic protein Anterior Gradient 2 is required for the interaction with BiP\/GRP78","volume":"430","author":"Ryu","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"8","key":"10.1016\/j.bcp.2025.117386_b0235","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1002\/ptr.6663","article-title":"Molecular mechanism of curcumin action in signaling pathways: review of the latest research","volume":"34","author":"Liczbi\u0144ski","year":"2020","journal-title":"Phytother. Res."},{"issue":"3","key":"10.1016\/j.bcp.2025.117386_b0240","first-page":"1343","article-title":"Curcumin attenuates resistance to irinotecan via induction of apoptosis of cancer stem cells in chemoresistant colon cancer cells","volume":"53","author":"Su","year":"2018","journal-title":"Int. J. Oncol."},{"issue":"3\u20134","key":"10.1016\/j.bcp.2025.117386_b0245","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1159\/000381029","article-title":"Irinotecan induces cell cycle arrest, but not apoptosis or necrosis, in Caco-2 and CW2 colorectal cancer cell lines","volume":"95","author":"Kaku","year":"2015","journal-title":"Pharmacology"},{"key":"10.1016\/j.bcp.2025.117386_b0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.jddst.2024.105848","article-title":"Co-delivery liposomes of irinotecan hydrochloride and curcumin in the synergistic treatment of colorectal cancer","volume":"98","author":"He","year":"2024","journal-title":"J. Drug Delivery Sci. Technol."},{"issue":"7","key":"10.1016\/j.bcp.2025.117386_b0255","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.3390\/ijms21072364","article-title":"Curcumin and colorectal cancer: from basic to clinical evidences","volume":"21","author":"Pricci","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.bcp.2025.117386_b0260","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s44164-022-00023-y","article-title":"Highlight: microfluidic devices for cancer metastasis studies","volume":"1","author":"Scemama","year":"2022","journal-title":"In vitro models"},{"issue":"4","key":"10.1016\/j.bcp.2025.117386_b0265","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1097\/CAD.0000000000000599","article-title":"Curcumin reverses irinotecan resistance in colon cancer cell by regulation of epithelial\u2013mesenchymal transition","volume":"29","author":"Zhang","year":"2018","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.bcp.2025.117386_b0270","article-title":"Effects of curcumin on 5-fluorouracil resistance of colon cancer cells through the PI3K\/AKT\/mTOR pathway via MACC1","volume":"56","author":"Ma","year":"2022","journal-title":"European J. Integrat. Med."},{"issue":"5","key":"10.1016\/j.bcp.2025.117386_b0275","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.21037\/tcr-21-689","article-title":"Curcumol increases the sensitivity of colon cancer to 5-FU by regulating Wnt\/\u03b2-catenin signaling","volume":"10","author":"Gao","year":"2021","journal-title":"Transl. Cancer Res."},{"issue":"2","key":"10.1016\/j.bcp.2025.117386_b0280","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1007\/s11095-008-9735-8","article-title":"Curcumin inhibits the activity of ABCG2\/BCRP1, a multidrug resistance-linked ABC drug transporter in mice","volume":"26","author":"Shukla","year":"2009","journal-title":"Pharm. Res."},{"issue":"10","key":"10.1016\/j.bcp.2025.117386_b0285","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1002\/ptr.6703","article-title":"Curcumin effect on cancer cells\u2019 multidrug resistance: an update","volume":"34","author":"Keyvani-Ghamsari","year":"2020","journal-title":"Phytother. Res."},{"issue":"8","key":"10.1016\/j.bcp.2025.117386_b0290","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1124\/dmd.108.020552","article-title":"Curcuminoids inhibit multiple human cytochromes P450, UDP-glucuronosyltransferase, and sulfotransferase enzymes, whereas piperine is a relatively selective CYP3A4 inhibitor","volume":"36","author":"Volak","year":"2008","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.bcp.2025.117386_b0295","doi-asserted-by":"crossref","first-page":"3893","DOI":"10.2147\/OTT.S199601","article-title":"Curcumin reverses oxaliplatin resistance in human colorectal cancer via regulation of TGF-\u03b2\/Smad2\/3 signaling pathway","volume":"12","author":"Yin","year":"2019","journal-title":"Onco Targets Ther."},{"issue":"4","key":"10.1016\/j.bcp.2025.117386_b0300","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1593\/tlo.09193","article-title":"Elimination of colon cancer stem-like cells by the combination of curcumin and FOLFOX","volume":"2","author":"Yu","year":"2009","journal-title":"Transl. Oncol."},{"issue":"1","key":"10.1016\/j.bcp.2025.117386_b0305","first-page":"1","article-title":"Proteomic analysis identifies proteins associated with curcumin-enhancing efficacy of irinotecan-induced apoptosis of colorectal cancer LOVO cell","volume":"7","author":"Zhu","year":"2014","journal-title":"Int. J. Clin. Exp. Pathol."},{"issue":"6","key":"10.1016\/j.bcp.2025.117386_b0310","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1021\/mp700113r","article-title":"Bioavailability of curcumin: problems and promises","volume":"4","author":"Anand","year":"2007","journal-title":"Mol. Pharm."},{"issue":"13","key":"10.1016\/j.bcp.2025.117386_b0315","doi-asserted-by":"crossref","first-page":"5719","DOI":"10.1039\/D1FO00942G","article-title":"One-step self-assembly of curcumin-loaded zein\/sophorolipid nanoparticles: physicochemical stability, redispersibility, solubility and bioaccessibility","volume":"12","author":"Yuan","year":"2021","journal-title":"Food Funct."},{"issue":"1","key":"10.1016\/j.bcp.2025.117386_b0320","doi-asserted-by":"crossref","DOI":"10.1111\/jfbc.13584","article-title":"Antioxidant properties of novel curcumin analogues: a combined experimental and computational study","volume":"45","author":"Slavova-Kazakova","year":"2021","journal-title":"J. Food Biochem."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295225006513?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295225006513?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T22:38:46Z","timestamp":1761777526000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295225006513"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":63,"alternative-id":["S0006295225006513"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2025.117386","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Curcumin reverses irinotecan-acquired resistance in DLD1 colorectal cancer cells: Insights from whole transcriptomic data","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2025.117386","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"117386"}}